More than 150 Plants in North America's Pharma-Biotech Industry Opened in 2021

SUGAR LAND--January 21, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--North America's Pharmaceutical & Biotech Industry opened 152 new plants in 2021. Comprising brownfield and grassroot facilities, the sites represent a potential total investment value of $8 billion, when including original construction costs with any planned expansions or additional phases. Interestingly, none of the plants were sourced from traditional "big pharma" companies.